Texas Governor Signs Bill to Test Psychedelics As PTSD Treatment for Veterans

,
Texas Gov. Greg Abbott signed a bill requiring the state to study the risks and benefits of psychedelics for veterans suffering with PTSD.

Red Light Holland CANNABIS Merger, Atai IPO, NUMI Uplists, MindMed & More (TRUFF, atai, Numi, MMED)

LOTS of news happened this week, one of the major ones being Red Light Holland's merger with a CANNABIS Company called Cresco. Other news we discuss in today's segment is atai Life Sciences Nasdaq uplisting, MindMed's new addition to the team, Numinus' Uplisting and Field Trip's upcoming financial results. Enjoy! Timestamps: 0:00 - Intro 1:00 - atai Life Sciences Nasdaq IPO 2:56 -Red Light Holland Merging With A Cannabis Company & Acquisition 7:26 -Numinus Wellness Uplists To The TSX 8:45 - MindMed Appoints Peter Bergethon To Their Scientific Advisory Board 10:36 - Field Trip's Upcoming Financial Results Links: atai Life Sciences ( NASDAQ: atai) https://www.cnbc.com/2021/06/18/peter-thiel-backed-psychedelic-start-ups-shares-pop-in-wall-street-debut.html Red Light Holland ( CSE: TRIP / OTC: TRUFF) Closes Acquisition of 80% of Happy Caps Mushroom Farm: https://ca.finance.yahoo.com/news/red-light-holland-closes-acquisition-122000805.html Red Light Holland is Merging with a Cannabis company called Creso Pharma to create The HighBrid Lab: https://www.newsfilecorp.com/release/87740/Creso-Pharma-and-Red-Light-Holland-Merge-to-Introduce-The-HighBrid-Lab-TM-a-Leading-Global-Psychedelics-x-Cannabis-Company-Specializing-in-Recreational-Products-Applied-Science-Technology-and-Innovation Numinus Wellness (OTC: LKYSF, TSX.V: NUMI) Uplists to Tier 1 on the TSX Venture Exchange: https://thecannabisstock.com/2021/06/18/numinus-wellness-gradu MindMed (NASDAQ: MNMD, NEO: MMED) Appoints Pharmaceutical Veteran, DR Peter Bergethon to their Scientific Advisory Board: https://www.prnewswire.com/news-releases/mindmed-appoints-pharmaceutical-veteran-peter-bergethon-md-to-scientific-advisory-board-301314501.html Field Trip Health (OTC: FTRPF, TSX: FTRP) Will Release Financial Results for its fiscal fourth quarter and full year 2021 ended March 31, 2021: https://ca.movies.yahoo.com/field-trip-health-ltd-announces-131000469.html https://www.meetfieldtrip.com/news/news-details/2021/Field-Trip-Health-Ltd.-Schedules-Fiscal-Fourth-Quarter-and-Full-Year-2021-Financial-Results-Conference-Call-for-Friday-June-25-2021-At-800-am-ET/default.aspx Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com editing:@themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #RedLightHolland #MindMed #atai
Atai Life Sciences Valued At More Than $3 Billion After IPO

Atai Life Sciences Valued At More Than $3 Billion After IPO

German psychedelic pharmaceutical company Atai Life Sciences is valued at more than $3 billion after its IPO listing on the Nasdaq.
Publicly-Traded Psychedelic Stocks

27 Publicly-Traded Psychedelic Stocks Investors Have Their Eyes On

These psychedelic stocks are all publicly trading. Take a look at the companies leading the psychedelic medicine revolution.
Psychedelic Business Spotlight: June 18, 2021

Psychedelic Business Spotlight: June 18, 2021

,
This week in psychedelic business news: Patent progress for biosynthetic psilocybin, psychedelics for brain health, and psychedelic and cannabis companies team up in the name of research.

Atai Life Sciences IPOing TOMORROW ( Is Atai a BUY?)

ATAI IPOS TOMORROW! It's finally happening! This Friday, on June 18th, 2021, the company I've been talking about for a while now, Atai Life Sciences, is set to IPO on the NASDAQ stock exchange, under ticker symbol "atai". This will automatically make Atai a runner for the title of the most advanced public psychedelic medicines company on the market. So in this episode, we'll discuss several things: 1. The details of the IPO 2. We'll take a look at their financials 3. Look at Atai Life Sciences' investment thesis 4. What I will be doing Enjoy the episode! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Website: https://thepsychedelicinvestor.com/ editing: @themyaholy Facebook: @thepsychedelicinvestor Music: www.bensound.com https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor https://www.atai.life/ DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #Atai #AtaiLifeSciences #AtaiIPO
Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression

Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression

Ketamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.

I Just SOLD Half My MINDMED Shares And I’m Crying 😢 (MMED / MNMD)

So I just sold about HALF of my MindMed shares. But BEFORE you all FREAK OUT AND UNSUBSCRIBE, watch the rest of this episode and I can ASSURE YOU, there's some good reasons there and none of them are about me losing faith in MMED/MNMD. I love MindMed. My MMED holdings have more than 10Xed since the company IPOed and I will keep the rest of my MindMed holdings probably forever! Enjoy the episode! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Website: https://thepsychedelicinvestor.com/ Music: www.bensound.com Video editing: @themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #MNMD #MindmedNews
Bringing Next-Gen Depression Treatment to Market: PharmaTher's Ketamine Patch

Bringing Next-Gen Depression Treatment to Market: PharmaTher’s Ketamine Patch

Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
Can Taking Psychedelics Change Your Political Beliefs? It's Complicated.

Can Taking Psychedelics Change Your Political Beliefs? It’s Complicated.

Will taking psychedelics turn you into a liberal hippie? Here's everything you need to know about psychedelics and political beliefs.